The identification and study of the complete repertoire of nuclear TCF4/β-catenin coactivator complex components dedicated to this transcriptional program is both required to unveil the key targets and mechanistic events responsible for initiation and progression of cancer and also critical to the definition of potential therapeutic targets in colorectal cancer. The gene discussed is TCF4; the disease is colorectal cancer.